142 related articles for article (PubMed ID: 8873440)
1. The role of mycophenolate mofetil in clinical renal transplantation.
Hodge EE
World J Urol; 1996; 14(4):249-55. PubMed ID: 8873440
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.
Halloran P; Mathew T; Tomlanovich S; Groth C; Hooftman L; Barker C
Transplantation; 1997 Jan; 63(1):39-47. PubMed ID: 9000658
[TBL] [Abstract][Full Text] [Related]
3. A placebo controlled study of mycophenolate mofetil used in combination with cyclosporine and corticosteroids for the prevention of acute rejection in renal allograft recipients: 1-year results. The European Mycophenolate Mofetil Cooperative Study Group.
Wiesel M; Carl S
J Urol; 1998 Jan; 159(1):28-33. PubMed ID: 9400430
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group.
Sollinger HW
Transplantation; 1995 Aug; 60(3):225-32. PubMed ID: 7645033
[TBL] [Abstract][Full Text] [Related]
5. A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation.
Behrend M
Clin Nephrol; 1996 May; 45(5):336-41. PubMed ID: 8738667
[TBL] [Abstract][Full Text] [Related]
6. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Mathew TH
Transplantation; 1998 Jun; 65(11):1450-4. PubMed ID: 9645801
[TBL] [Abstract][Full Text] [Related]
7. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
8. [Mycophenolate mofetil--a new immunosuppressive agent].
Bergan S; Albrechtsen D; Fauchald P
Tidsskr Nor Laegeforen; 1996 Aug; 116(20):2439-41. PubMed ID: 8928103
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.
Fulton B; Markham A
Drugs; 1996 Feb; 51(2):278-98. PubMed ID: 8808168
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil in kidney transplantation.
Lui SL; Halloran PF
Curr Opin Nephrol Hypertens; 1996 Nov; 5(6):508-13. PubMed ID: 8978998
[TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil in pediatric renal transplantation.
Weber LT; Höcker B; Mehls O; Tönshoff B
Minerva Urol Nefrol; 2003 Mar; 55(1):91-9. PubMed ID: 12773970
[TBL] [Abstract][Full Text] [Related]
12. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection.
Simmons WD; Rayhill SC; Sollinger HW
Drug Saf; 1997 Aug; 17(2):75-92. PubMed ID: 9285199
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
[TBL] [Abstract][Full Text] [Related]
14. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
[TBL] [Abstract][Full Text] [Related]
15. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil.
Sollinger HW
Kidney Int Suppl; 1995 Dec; 52():S14-7. PubMed ID: 8587275
[TBL] [Abstract][Full Text] [Related]
17. Superior efficacy of enteric-coated mycophenolate vs mycophenolate mofetil in de novo transplant recipients: pooled analysis.
Salvadori M; Bertoni E; Budde K; Holzer H; Civati G; Lien B; Arns W
Transplant Proc; 2010 May; 42(4):1325-8. PubMed ID: 20534293
[TBL] [Abstract][Full Text] [Related]
18. Mycophenolate mofetil for maintenance therapy in kidney transplantation.
Gonwa TA
Clin Transplant; 1996 Feb; 10(1 Pt 2):128-30. PubMed ID: 8680049
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience.
Ross DJ; Waters PF; Levine M; Kramer M; Ruzevich S; Kass RM
J Heart Lung Transplant; 1998 Aug; 17(8):768-74. PubMed ID: 9730425
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil: a unique immunosuppressive agent.
Hood KA; Zarembski DG
Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
